Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8265 EUR | -2.02% | -2.76% | -19.84% |
05-08 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.84% | 616M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Reports Data on Leniolisib Trial to Treat Rare Immunodeficiency